Literature DB >> 27353402

Liver regeneration - mechanisms and models to clinical application.

Stuart J Forbes1, Philip N Newsome2.   

Abstract

Liver regeneration has been studied for many decades and the mechanisms underlying regeneration of the normal liver following resection or moderate damage are well described. A large number of factors extrinsic (such as bile acids and circulating growth factors) and intrinsic to the liver interact to initiate and regulate liver regeneration. Less well understood, and more clinically relevant, are the factors at play when the abnormal liver is required to regenerate. Fatty liver disease, chronic scarring, prior chemotherapy and massive liver injury can all inhibit the normal programme of regeneration and can lead to liver failure. Understanding these mechanisms could enable the rational targeting of specific therapies to either reduce the factors inhibiting regeneration or directly stimulate liver regeneration. Although animal models of liver regeneration have been highly instructive, the clinical relevance of some models could be improved to bridge the gap between our in vivo model systems and the clinical situation. Likewise, modern imaging techniques such as spectroscopy will probably improve our understanding of whole-organ metabolism and how this predicts the liver's regenerative capacity. This Review describes briefly the mechanisms underpinning liver regeneration, the models used to study this process, and discusses areas in which failed or compromised liver regeneration is clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27353402     DOI: 10.1038/nrgastro.2016.97

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  95 in total

1.  Hepatobiliary Quiz Answers-19 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-10-03

2.  De-liver CLiPs and revitalize hepatocytes.

Authors:  Ali-Reza Sadri; Saeid Amini-Nik
Journal:  Stem Cell Investig       Date:  2017-04-17

Review 3.  γδ T cells in liver diseases.

Authors:  Xuefu Wang; Zhigang Tian
Journal:  Front Med       Date:  2018-02-14       Impact factor: 4.592

4.  Gene Expression in the Liver Remnant Is Significantly Affected by the Size of Partial Hepatectomy: An Experimental Rat Study.

Authors:  Michelle Meier; Anders Riegels Knudsen; Kasper Jarlhelt Andersen; Niels Christian Bjerregaard; Uffe Birk Jensen; Frank Viborg Mortensen
Journal:  Gene Expr       Date:  2017-05-09

5.  mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.

Authors:  Meng Xu; Haichuan Wang; Jingxiao Wang; Deviana Burhan; Runze Shang; Pan Wang; Yi Zhou; Rong Li; Bingyong Liang; Katja Evert; Kirsten Utpatel; Zhong Xu; Xinhua Song; Li Che; Diego F Calvisi; Bruce Wang; Xi Chen; Yong Zeng; Xin Chen
Journal:  Am J Pathol       Date:  2020-02-05       Impact factor: 4.307

6.  Regulation of hepatocyte cell cycle re-entry by RNA polymerase II-associated Gdown1.

Authors:  Miki Jishage; Robert G Roeder
Journal:  Cell Cycle       Date:  2020-11-25       Impact factor: 4.534

Review 7.  The Matrisome, Inflammation, and Liver Disease.

Authors:  Christine E Dolin; Gavin E Arteel
Journal:  Semin Liver Dis       Date:  2020-01-07       Impact factor: 6.115

Review 8.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

9.  ER Stress Inhibits Liver Fatty Acid Oxidation while Unmitigated Stress Leads to Anorexia-Induced Lipolysis and Both Liver and Kidney Steatosis.

Authors:  Diane DeZwaan-McCabe; Ryan D Sheldon; Michelle C Gorecki; Deng-Fu Guo; Erica R Gansemer; Randal J Kaufman; Kamal Rahmouni; Matthew P Gillum; Eric B Taylor; Lynn M Teesch; D Thomas Rutkowski
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

10.  Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.

Authors:  Caitlin VanLith; Rebekah Guthman; Clara T Nicolas; Kari Allen; Zeji Du; Dong Jin Joo; Scott L Nyberg; Joseph B Lillegard; Raymond D Hickey
Journal:  Hum Gene Ther       Date:  2018-06-22       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.